Masakazu Naohara

The Decreased in Vivo Clearance of CYP2D6 Substrates by CYP2D6*10 Might Be Caused Not Only by the Low-Expression but Also by Low Affinity of CYP2D6

Tsuyoshi Fukuda, Yuko Nishida, Susumu Imaoka et al. · Archives of Biochemistry and Biophysics · 2000 · 81 citations

Molecular Pharmacology, Cyp2d6 Substrates, Molecular Physiology +8

Quantitative Analysis of Constitutive and Inducible CYPs mRNA Expression in the HepG2 Cell Line Using Reverse Transcription-Competitive PCR

Akihiko Sumida, Shuichi Fukuen, Isamu Yamamoto et al. · Biochemical and Biophysical Research Communications · 2000 · 60 citations

Transcriptional Regulation, Systems Biology, Signal Transduction +9

Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers

Masahiro Otani, Tsuyoshi Fukuda, Masakazu Naohara et al. · European Journal of Clinical Pharmacology · 2003 · 22 citations

Healthy Adult Volunteers, Molecular Pharmacology, Medicine +5

The Frequency of Candidate Alleles for CYP2D6 Genotyping in the Japanese Population with an Additional Respect to the −1584C to G Substitution

Yuka Ikenaga, Tsuyoshi Fukuda, Kazuhiro Fukuda et al. · Drug Metabolism and Pharmacokinetics · 2005 · 22 citations

Novel Structure of the CYP2D6 Gene that Confuses Genotyping for the CYP2D6*5 Allele

Tsuyoshi Fukuda, Hiromi Maune, Yuka Ikenaga et al. · Drug Metabolism and Pharmacokinetics · 2005 · 16 citations